Has Christopher Demers, MD received payments from drug or device companies?

Yes. Drug and device makers reported $70,738 in general payments to Christopher Demers, MD across 162 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christopher Demers, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christopher Demers, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christopher Demers, MD

Neurological Surgery · Reno, NVNPI 1427275676

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $45,140 of the $70,738 with a category attached, or 63.8%. Medtronic accounts for 93.1% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $30,024, more than ten times the $264 reported in 2019.

$70,738in general payments, 2019–2025

Across 162 payments — averaging $436.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$66K
Abbott$3K
Centinel Spine, LLC$1K
Globus Medical$573
Johnson & Johnson$173
Medexus Pharma, Inc.$101
plus $148 from 3 others

What the payments were for

Speaking & faculty fees$45,14064%
Travel & lodging$19,68128%
Food & beverage$5,9178%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	129	$65,849
Abbott	17	$2,569
Centinel Spine, LLC	9	$1,326
Globus Medical	2	$573
Johnson & Johnson	1	$173
Medexus Pharma, Inc.	1	$101
Edwards Lifesciences	1	$96
Surgical Theater. Inc.	1	$34
Theragen, Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$70,738 in reported general payments places this provider in the 75th percentile of 45 neurological surgery providers in Nevada.

See all neurological surgery providers in Nevada →

Medicare billing

Part B allowed, 2024

$320,559

Medicare patients

649

Services billed

14,389

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Reno

Edward PerryReno$196K
Michael SongReno$154K
James LynchReno$112K
Lali SekhonReno$80K
Jay MorganReno$43K
Angelique Sao Mai TayReno$39K
Rima RindlerReno$31K
Shane AbdunnurReno$24K
Marshall TolbertReno$8K
Michael MooreReno$2K

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →